{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:56:31Z","timestamp":1788692191054,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jacc.2017.05.057","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T14:55:36Z","timestamp":1500908136000},"page":"607-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Should We Still Have Bare-Metal Stents\u00a0Available in Our Catheterization\u00a0Laboratory?"],"prefix":"10.1016","volume":"70","author":[{"given":"Antonio","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Briguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.05.057_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A\u00a0randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.05.057_bib2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.05.057_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A\u00a0polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.05.057_bib4","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib5","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/eurheartj\/ehl282","article-title":"Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis","volume":"27","author":"Nordmann","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCINTERVENTIONS.108.844985","article-title":"Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry","volume":"2","author":"Lagerqvist","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2017.05.057_bib7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib8","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1161\/CIRCULATIONAHA.107.688416","article-title":"Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7\u20138, 2006","volume":"115","author":"Laskey","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"L\u00fcscher","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib10","doi-asserted-by":"crossref","first-page":"I25","DOI":"10.1093\/eurheartj\/sun039","article-title":"Duration of antiplatelet therapy following intracoronary stenting: are changes needed?","volume":"10","author":"Byrne","year":"2008","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jacc.2017.05.057_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9149(03)00669-6","article-title":"Usefulness of a cobalt chromium coronary stent alloy","volume":"92","author":"Kereiakes","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","article-title":"Intracoronary stenting and angiographic results: strut\u00a0thickness effect on restenosis outcome (ISAR-STEREO-2) trial","volume":"41","author":"Pache","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","article-title":"A\u00a0meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease","volume":"50","author":"Sch\u00f6mig","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"Joner","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jcin.2016.03.038","article-title":"Stent thrombosis with drug-eluting stents and bioresorbable scaffolds: evidence from a network meta-analysis of 147 trials","volume":"9","author":"Kang","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.05.057_bib16","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib18","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.05.057_bib19","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(11)61672-3","article-title":"Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial","volume":"378","author":"Stefanini","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.2012.10065","article-title":"Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial","volume":"308","author":"R\u00e4ber","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.05.057_bib21","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib23","doi-asserted-by":"crossref","first-page":"f6625","DOI":"10.1136\/bmj.f6625","article-title":"Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis","volume":"347","author":"Bangalore","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2017.05.057_bib24","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/eurheartj\/ehs086","volume":"33","author":"Stefanini","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib25","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2017.05.057_bib26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study","volume":"125","author":"R\u00e4ber","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.05.057_bib28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of \u2018new-generation\u2019 drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0735-1097(02)01989-7","article-title":"In-stent restenosis in small coronary arteries: impact of strut thickness","volume":"40","author":"Briguori","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2004.08.055","article-title":"Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system","volume":"95","author":"Sketch","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2014.04.269","article-title":"Trend in the use of drug eluting stents in the United States: insight from over 8.1 million coronary interventions","volume":"175","author":"Bangalore","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib32","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.05.057_bib33","doi-asserted-by":"crossref","first-page":"e0142075","DOI":"10.1371\/journal.pone.0142075","article-title":"Surface modification of biodegradable polymers towards better biocompatibility and lower thrombogenicity","volume":"10","author":"Rudolph","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2017.05.057_bib34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/CIRCINTERVENTIONS.114.001341","article-title":"Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations","volume":"7","author":"Magalhaes","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2017.05.057_bib35","doi-asserted-by":"crossref","first-page":"e002427","DOI":"10.1161\/CIRCINTERVENTIONS.115.002427","article-title":"Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents","volume":"8","author":"Koppara","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2017.05.057_bib36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCINTERVENTIONS.113.000120","article-title":"Impact of stent surface on thrombogenicity and vascular healing: a comparative analysis of metallic and polymeric surface","volume":"6","author":"Eppihimer","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2017.05.057_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib38","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.2174\/138161210794454879","article-title":"Pathobiology of stent thrombosis after drug-eluting stent implantation","volume":"16","author":"Vorpahl","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jacc.2017.05.057_bib39","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ahj.2005.08.011","article-title":"Bare metal stent restenosis is not a benign clinical entity","volume":"151","author":"Chen","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib41","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib42","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12\u00a0months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Sch\u00fcpke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A\u00a0new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib44","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.05.057_bib45","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib46","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.amjcard.2016.06.061","article-title":"Trends in bare-metal stent use in the United States in patients aged\u00a0\u226565 years (from the CathPCI Registry)","volume":"118","author":"Rymer","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib47","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","article-title":"Heart disease and stroke statistics\u20142013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib48","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jacc.2012.11.049","article-title":"Why are we still using coronary bare-metal stents?","volume":"61","author":"Morice","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib49","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib50","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jacc.2016.02.064","article-title":"Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS","volume":"67","author":"Baber","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib51","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib52","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.05.057_bib53","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib54","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib56","first-page":"961","article-title":"Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study","volume":"38","author":"Naber","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacc.2016.10.009","article-title":"2-year outcomes of high bleeding risk patients after polymer-free drug-coated stents","volume":"69","author":"Garot","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib58","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","article-title":"Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates","volume":"65","author":"Valgimigli","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib59","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jamcollsurg.2011.12.011","article-title":"The incidence and timing of noncardiac surgery after cardiac stent implantation","volume":"214","author":"Hawn","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jacc.2017.05.057_bib60","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2017.02.012","article-title":"Use of antiplatelet therapy\/DAPT for post-PCI patients undergoing noncardiac surgery","volume":"69","author":"Benerjee","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib61","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCINTERVENTIONS.109.934703","article-title":"Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery","volume":"3","author":"Cruden","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2017.05.057_bib62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCINTERVENTIONS.108.830158","article-title":"Noncardiac surgery and bleeding after percutaneous coronary intervention","volume":"2","author":"To","year":"2009","journal-title":"Circ Cardiovac Interv"},{"key":"10.1016\/j.jacc.2017.05.057_bib63","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.CIR.99.2.248","article-title":"Safety and efficacy of ticlopidine for only 2\u00a0weeks after successful intracoronary stent placement","volume":"99","author":"Berger","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2008.02.091","article-title":"Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation","volume":"102","author":"Xie","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib65","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/hrt.2007.118679","article-title":"Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography","volume":"94","author":"Chen","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2017.05.057_bib66","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jacc.2016.05.085","article-title":"Outcomes of patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"68","author":"Sutton","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib67","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4244\/EIJV10I9A174","article-title":"Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement","volume":"10","author":"Capodanno","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2017.05.057_bib68","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomized, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib69","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.05.057_bib70","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1093\/eurheartj\/ehp275","article-title":"Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period","volume":"30","author":"Schulz","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib71","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib72","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1253\/circj.CJ-14-0792","article-title":"Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"78","author":"Kiviniemi","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2017.05.057_bib73","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0735-1097(02)02597-4","article-title":"Clinical restenosis after coronary stenting: perspective from multicenter clinical trials","volume":"40","author":"Cutlip","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib74","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(05)67221-2","article-title":"Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivit\u00e4ts Trial (BASKET)","volume":"366","author":"Kaiser","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib75","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/ehn516","article-title":"Long-term benefit\u2013risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET","volume":"30","author":"Pfisterer","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.05.057_bib76","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa1009406","article-title":"Drug-eluting versus bare-metal stents in large coronary arteries","volume":"363","author":"Kaiser","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.05.057_bib77","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(15)00548-6","article-title":"Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial","volume":"387","author":"Sabat\u00e9","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcin.2013.07.012","volume":"7","author":"Sabat\u00e9","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.05.057_bib79","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcin.2011.03.018","article-title":"Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry","volume":"4","author":"Brilakis","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.05.057_bib80","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jcin.2010.08.019","article-title":"Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: a systematic review and meta-analysis","volume":"3","author":"Wiisanen","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.05.057_bib81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCINTERVENTIONS.110.949735","article-title":"Drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a Bayesian meta-analysis","volume":"3","author":"Paradis","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2017.05.057_bib82","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ccd.22720","article-title":"Safety and efficacy of drug eluting stents compared with bare\u00a0metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients","volume":"77","author":"Hakeem","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2017.05.057_bib83","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.jcin.2016.09.035","article-title":"Does current evidence favor drug-eluting stents over bare-metal stents for saphenous venous grafts interventions? Insights from an updated meta-analysis of randomized controlled trials","volume":"9","author":"Bavishi","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.05.057_bib84","author":"Jeger"},{"key":"10.1016\/j.jacc.2017.05.057_bib85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000137699","article-title":"Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions","volume":"112","author":"Jeger","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2017.05.057_bib86","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(11)61255-5","article-title":"Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial","volume":"378","author":"Mehilli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.05.057_bib87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jacc.2007.05.010","article-title":"Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial","volume":"50","author":"Vermeersch","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib88","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2008.11.029","article-title":"A\u00a0randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"53","author":"Brilakis","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib89","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archinternmed.2012.3093","article-title":"Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice","volume":"172","author":"Amin","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2017.05.057_bib90","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.110.978593","article-title":"Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry","volume":"124","author":"Venkitachalam","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.05.057_bib91","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCOUTCOMES.110.960187","article-title":"Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice","volume":"4","author":"Schafer","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2017.05.057_bib92","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjcard.2012.05.006","article-title":"Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial)","volume":"110","author":"Amin","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.05.057_bib93","doi-asserted-by":"crossref","first-page":"e000445","DOI":"10.1136\/openhrt-2016-000445","article-title":"Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention","volume":"3","author":"Baschet","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2017.05.057_bib94","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"B\u00f8naa","year":"2016","journal-title":"N\u00a0Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2017.08.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717376064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717376064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T20:56:41Z","timestamp":1535576201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717376064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0735109717376064"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.05.057","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jacc.2017.08.007","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should We Still Have Bare-Metal Stents\u00a0Available in Our Catheterization\u00a0Laboratory?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.05.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}